Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

Similar articles for PubMed (Select 24205903)

1.

Mifepristone: a potential clinical agent based on its anti-progesterone and anti-glucocorticoid properties.

Sun Y, Fang M, Davies H, Hu Z.

Gynecol Endocrinol. 2014 Mar;30(3):169-73. doi: 10.3109/09513590.2013.856410. Epub 2013 Nov 11. Review.

PMID:
24205903
2.

Mifepristone (RU486): a review.

Mahajan DK, London SN.

Fertil Steril. 1997 Dec;68(6):967-76. Review.

PMID:
9418681
3.

Clinical applications of the antiprogestins.

Kettel LM.

Clin Obstet Gynecol. 1995 Dec;38(4):921-34. Review. No abstract available.

PMID:
8616987
4.

Antiprogestins: mechanism of action and contraceptive potential.

Spitz IM, Croxatto HB, Robbins A.

Annu Rev Pharmacol Toxicol. 1996;36:47-81. Review.

PMID:
8725382
5.

Clinical uses of antiprogestogens.

Van Look PF, von Hertzen H.

Hum Reprod Update. 1995 Jan;1(1):19-34. Review.

PMID:
9080204
6.

[Clinical application of mifepristone in obstetrics and gynecology].

Weng L.

Zhonghua Fu Chan Ke Za Zhi. 1999 May;34(5):261-4. Chinese. No abstract available.

PMID:
11326928
7.

Mifepristone: current knowledge and emerging prospects.

Kakade AS, Kulkarni YS.

J Indian Med Assoc. 2014 Jan;112(1):36-40. Review.

PMID:
25935948
8.

Mifepristone: where do we come from and where are we going? Clinical development over a quarter of a century.

Spitz IM.

Contraception. 2010 Nov;82(5):442-52. doi: 10.1016/j.contraception.2009.12.012. Epub 2010 Feb 1. Review.

PMID:
20933118
9.

Mifepristone: contraceptive and non-contraceptive uses.

Ho PC, Yu Ng EH, Tang OS.

Curr Opin Obstet Gynecol. 2002 Jun;14(3):325-30. Review.

PMID:
12032390
10.

RU486 (mifepristone): mechanisms of action and clinical uses.

Cadepond F, Ulmann A, Baulieu EE.

Annu Rev Med. 1997;48:129-56. Review.

PMID:
9046951
11.

Mifepristone (RU 486): current knowledge and future prospects.

Goldberg JR, Plescia MG, Anastasio GD.

Arch Fam Med. 1998 May-Jun;7(3):219-22. Review.

PMID:
9596454
12.

Clinical applications of mifepristone.

Tang OS, Ho PC.

Gynecol Endocrinol. 2006 Dec;22(12):655-9. Review.

PMID:
17162706
13.

The use of the glucocorticoid receptor antagonist mifepristone in Cushing's syndrome.

Castinetti F, Brue T, Conte-Devolx B.

Curr Opin Endocrinol Diabetes Obes. 2012 Aug;19(4):295-9. doi: 10.1097/MED.0b013e32835430bf. Review.

PMID:
22543346
14.

A new therapeutic approach in the medical treatment of Cushing's syndrome: glucocorticoid receptor blockade with mifepristone.

Fleseriu M, Molitch ME, Gross C, Schteingart DE, Vaughan TB 3rd, Biller BM.

Endocr Pract. 2013 Mar-Apr;19(2):313-26. doi: 10.4158/EP12149.RA. Review.

PMID:
23337135
15.

The use of mifepristone in the treatment of Cushing's syndrome.

Carroll T, Findling JW.

Drugs Today (Barc). 2012 Aug;48(8):509-18. doi: 10.1358/dot.2012.48.8.1841299.

PMID:
22916338
16.

[Present and potential uses of mifepristone in gynecology, obstetrics and other medical specialties].

Weingertner AS, Hamid D, Baldauf JJ, Nisand I.

J Gynecol Obstet Biol Reprod (Paris). 2004 Dec;33(8):692-702. Review. French.

17.

Mifepristone: treatment of Cushing's syndrome.

Sartor O, Cutler GB Jr.

Clin Obstet Gynecol. 1996 Jun;39(2):506-10. Review.

PMID:
8734015
18.

Mifepristone for management of Cushing's syndrome.

Morgan FH, Laufgraben MJ.

Pharmacotherapy. 2013 Mar;33(3):319-29. doi: 10.1002/phar.1202. Epub 2013 Feb 21. Review.

PMID:
23436494
19.

Clinical pharmacokinetics of mifepristone.

Heikinheimo O.

Clin Pharmacokinet. 1997 Jul;33(1):7-17.

PMID:
9250420
20.

Mifepristone: bioavailability, pharmacokinetics and use-effectiveness.

Sarkar NN.

Eur J Obstet Gynecol Reprod Biol. 2002 Mar 10;101(2):113-20. Review.

PMID:
11858883
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk